ACW 4.00% 2.6¢ actinogen medical limited

Momentum & Belief, page-7

  1. 60 Posts.
    lightbulb Created with Sketch. 32
    For some reason they do not want to do it in so called normal memory aging related decline, possibly memory decline within normal limits is not yet classified as a disease hence no therapeutic market approvals to align the target therapy from a regulatory point of view to generate sales - agree the market would be huge - they had a significant signal in normative aging study.





 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
2.6¢
Change
0.001(4.00%)
Mkt cap ! $76.57M
Open High Low Value Volume
2.5¢ 2.7¢ 2.5¢ $192.6K 7.531M

Buyers (Bids)

No. Vol. Price($)
15 4201185 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 8694 1
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.